WO2024218193 - METHODS FOR IMPROVING INDIVIDUAL SERIAL DIAGNOSTIC TESTING
National phase entry:
Publication Number
WO/2024/218193
Publication Date
24.10.2024
International Application No.
PCT/EP2024/060497
International Filing Date
18.04.2024
Title **
[English]
METHODS FOR IMPROVING INDIVIDUAL SERIAL DIAGNOSTIC TESTING
[French]
PROCÉDÉS POUR AMÉLIORER DES TESTS DIAGNOSTIQUES INDIVIDUELS EN SÉRIE
Applicants **
RANDOX LABORATORIES LTD
Ardmore
55 Diamond Road
Crumlin Antrim BT29 4QY, GB
Inventors
INNOCENZI, Paul John
Randox laboraories Ltd
Ardmore
55 Diamond Road
Crumlin Antrim BT29 4QY, GB
FITZGERALD, Stephen Peter
Randox Laboratories ltd
Ardmore
55 Diamond Road
Crumlin Antrim BT294QY, GB
MCCONNELL, Ivan
Randox Laboratories ltd
Ardmore
55 Diamond Road
Crumlin Antrim BT294QY, GB
Priority Data
2305864.7
21.04.2023
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1105 | |
| EPO | Filing, Examination | 4666 | |
| Japan | Filing | 597 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 9653 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
A method of supporting diagnostic decisions based on biochemical measurements is presented. The use of a correction factor derived from population biochemical measurement values when applied to a follow-on biochemical measurement value of an individual mitigates pre-analytical and analytical variation enabling more robust clinical analyses and decisions to be made.[French]
L'invention concerne un procédé d'aide aux décisions diagnostiques sur la base de mesures biochimiques. L'utilisation d'un facteur de correction dérivé de valeurs de mesure biochimique de la population, lorsqu'il est appliqué à une valeur de mesure biochimique de suivi d'un individu atténue les variations pré-analytiques et analytiques, ce qui permet d'effectuer des analyses cliniques et de prendre des décisions cliniques plus solides.